Delineation of the Structural Elements of Oriental Liver Fluke PLA2 Isoforms for Potent Drug Designing
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Clonorchis sinensis or the Chinese liver fluke is one of the most prevalent parasites affecting a major population in the oriental countries. The parasite lacks lipid generating mechanisms but is exposed to fatty acid rich bile in the liver. A secretory phospholipase A2, an enzyme that breaks down complex lipids, is important for the growth of the parasite. The enzyme is also implicated in the pathogenesis leading up to the hepatic fibrosis and its complications including cancer. The five isoforms of this particular enzyme from the parasite therefore qualify as potential drug targets. In this study, a detailed structural and ligand binding analysis of the isoforms has been done by modeling. The overall three dimensional structures of the isoforms are well conserved with three helices and a β-wing stabilized by four disulfide bonds. There are characteristic differences at the calcium binding loop, hydrophobic channel and the C-terminal domain that can potentially be exploited for drug binding. But the most significant feature pertains to the catalytic site where the isoforms exhibit three variations of either a histidine-aspartate-tyrosine or histidine-glutamate-tyrosine or histidine-aspartate-phenylalanine. Molecular docking studies show that isoform specific residues and their conformations in the substrate binding hydrophobic channel make unique interactions with certain inhibitor molecules resulting in a perfect tight fit. The proposed ligand molecules have a predicted affinity in micro-molar to nano-molar range. Interestingly, few of the ligand binding interaction patterns is in accordance to the phylogenetic studies to thereby establish the usefulness of evolutionary mechanisms in aiding ligand design. The molecular diversity of the parasitic PLA2 described in this study provides a platform for personalized medicine in the therapeutics of clonorchiasis.
- Lun ZR, Gasser RB, Lai DH, Li AX, Zhu XQ, Yu XB, et al. Clonorchiasis: a key foodborne zoonosis in China. Lancet Infect Dis. 2005;5:31–41. CrossRef
- Li T, He S, Zhao H, Zhao G, Zhu XQ. Major trends in human parasitic diseases in China. Trends Parasitol. 2010;26:264–70. CrossRef
- Huang Y, Chen W, Wang X, Liu H, Chen Y, Guo L, et al. The carcinogenic liver fluke, Clonorchis sinensis: new assembly, reannotation and analysis of the genome and characterization of tissue transcriptomes. PLoS One. 2013;8:e54732. CrossRef
- Murakami M, Sato H, Taketomi Y, Yamamoto K. Integrated lipidomics in the secreted phospholipase A2 biology. Int J Mol Sci. 2011;12:1474–95. CrossRef
- Wang X, Chen W, Huang Y, Sun J, Men J, Liu H, et al. The draft genome of the carcinogenic human liver fluke Clonorchis sinensis. Genome Biol. 2011;12:R107. CrossRef
- Hu F, Hu X, Ma C, Zhao J, Xu J, Yu X. Molecular characterization of a novel Clonorchis sinensis secretory phospholipase A(2) and investigation of its potential contribution to hepatic fibrosis. Mol Biochem Parasitol. 2009;167:127–34. CrossRef
- Zhang F, Liang P, Chen W, Wang X, Hu Y, Liang C, et al. Stage-specific expression, immunolocalization of Clonorchis sinensis lysophospholipase and its potential role in hepatic fibrosis. Parasitol Res. 2013;12:737–49. CrossRef
- Hariprasad G, Kaur P, Srinivasan A, Singh TP, Kumar M. Structural analysis of secretory phospholipase A2 from Clonorchis sinensis: therapeutic implications for hepatic fibrosis. J Mol Model. 2012;18:3139–45. CrossRef
- Thompson JD, Gibson TJ, Higgins DG. Multiple sequence alignment using ClustalW and ClustalX. Curr Protoc Bioinformatics. 2002;2(2):3.
- Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modeling. Bioinformatics. 2006;22:195–201. CrossRef
- De Lano WL. The PyMOL molecular graphics system. San Carlos: DeLano Scientific; 2002.
- Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst. 1993;26:283–91. CrossRef
- Thomsen R, Christensen MH. MolDock: a new technique for high-accuracy molecular docking. J Med Chem. 2006;49:3315–21. CrossRef
- Gehlhaar DK, Verkhivker G, Rejto PA, Fogel DB, Fogel LJ, Freer ST. Docking conformationally flexible small molecules into a protein binding site through evolutionary programming. Proceedings of the fourth international conference on evolutionary programming. 1995;615–627.
- Yang JM, Chen CC. GEMDOCK: a generic evolutionary method for molecular docking. Proteins. 2004;55:288–304. CrossRef
- Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28:2731–9. CrossRef
- Scott DL, Otwinowski Z, Gelb MH, Sigler PB. Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue. Science. 1990;250:1563–6. CrossRef
- Hariprasad G, Baskar S, Das U, Ethayathulla AS, Kaur P, Singh TP, et al. Cloning, sequence analysis and homology modeling of a novel phospholipase A2 from Heterometrus fulvipes (Indian black scorpion). DNA Seq. 2007;18:242–6. CrossRef
- Pan YH, Yu BZ, Singer AG, Ghomashchi F, Lameau G, Gelb MH, et al. Crystal structure of human group × secreted phospholipase A2 electrostatically neutral interfacial surface targets zwitterionic membrane. J Biol Chem. 2002;277:29086–93. CrossRef
- Jabeen T, Singh N, Singh RK, Ethayathulla AS, Sharma S, Srinivasan A, et al. Crystal structure of a novel phospholipase A2 from Naja naja sagittifera with a strong anti-coagulant activity. Toxicon. 2005;46:865–75. CrossRef
- Jasti J, Paramasivam M, Srinivasan A, Singh TP. Structure of an acidic phospholipase A2 from Indian saw-scaled viper (Echis carinatus) at 2.6 Å resolution reveals a novel intermolecular interaction. Acta Crystallogr D. 2004;60:66–72. CrossRef
- Hariprasad G, Kumar M, Srinivasan A, Kaur P, Singh TP, Jithesh O. Group III phospholipase A2 from the scorpion, Mesobuthus tamulus: targeting and reversible inhibition by native peptides. Int J Biol Macromol. 2011;48:423–31. CrossRef
- Hariprasad G, Kumar M, Kaur P, Singh TP, Kumar RP. Human group III PLA2 as a drug target: structural analysis and inhibitor binding studies. Int J Biol Macromol. 2010;47:496–501. CrossRef
- Hariprasad G, Saravanan K, Baskar S, Das U, Sharma S, Kaur P, et al. Group III PLA2 from the scorpion, Mesobuthus tamulus: cloning and recombinant expression in E. coli. Electron J Biotechnol. 2009;12:3.
- Valentin E, Ghomashchi F, Gelb MH, Lazdunski M, Lambeau G. Novel human secreted phospholipase A(2) with homology to the group III bee venom enzyme. J Biol Chem. 2000;275:7492–6. CrossRef
- Nicolas JP, Lin Y, Lambeau G, Ghomashchi F, Lazdunski M, Gelb MH. Localization of structural elements of bee venom phospholipase A2 involved in N-type receptor binding and neurotoxicity. J Biol Chem. 1997;272:7173–81. CrossRef
- Dupureur CM, Yu BZ, Jain MK, Noel JP, Deng T, Li Y, et al. Phospholipase A2 engineering Structural and functional roles of highly conserved active site residues tyrosine-52 and tyrosine-73. Biochemistry. 1992;31:6402–13. CrossRef
- Delineation of the Structural Elements of Oriental Liver Fluke PLA2 Isoforms for Potent Drug Designing
Indian Journal of Clinical Biochemistry
- Print ISSN
- Online ISSN
- Springer India
- Additional Links
- Clonorchis sinensis
- Structural analysis
- Isoform specific potent drug designing
- Phospholipase A2